New GLP-1 Semaglutide Still Largely Unknown to Endocrinologists New GLP-1 Semaglutide Still Largely Unknown to Endocrinologists

Medscape Medical News poll respondents said obese patients with diabetes whose condition is poorly controlled would benefit the most from semaglutide.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news